Penn Medicine Provider
Gynecologic Oncology
Dimitrios Nasioudis, MD
Accepting new patients
Sees patients age 18 and up
Jordan Center for Gynecologic Cancers
Make an appointmentCall 800-789-7366

About me

  • Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Aristotelian University of Thessaloniki
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Nasioudis is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM. Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma , Int J Gynecol Cancer: 2025

Mulugeta-Gordon L, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D. Quality of adjuvant radiation therapy and impact on the survival of patients with lymph node-positive squamous cell carcinoma of the vulva , Int J Gynecol Cancer: 2025

Tubridy E, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D. Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma , Int J Gynecol Cancer: 2025

Caruso G, Kumar A, Langstraat CL, McGree ME, Fought AJ, Harrington S, Nasioudis D, Aletti GD, Colombo N, Giuntoli RL, Cliby W. Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer , Gynecol Oncol: 2025

Nasioudis D, Latif NA, Gysler S, Giuntoli RL 2nd, Kim SH, Ko EM. Premature adoption of adjuvant chemotherapy for locally advanced cervical carcinoma before the OUTBACK trial: cautionary tale on outcomes , Int J Gynecol Cancer, 34: 2024,1874-1880

Caruso G, Langstraat CL, Kumar A, McGree ME, Fought AJ, Nasioudis D, Aletti GD, Colombo N, Giuntoli RL, Cliby WA. Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer , Gynecol Oncol: 2024

Giannopoulos S, Naeem S, Nasioudis D, Gossner G, Burke WM, Orfanelli T. Value of surgical lymph node assessment for patients with vulvar melanoma , Eur J Cancer: 2024

Hicks-Courant K, Ko EM, Matsuo K, Melamed A, Nasioudis D, Rauh-Hain JA, Uppal S, Wright JD, Ramirez PT. Secondary databases in gynecologic cancer research , Int J Gynecol Cancer, 34: 2024,1619-1629

Nasioudis D, Pashankar FD. Management of recurrent and persistent malignant ovarian germ cell tumors: a narrative review , Int J Gynecol Cancer, 34: 2024,1454-1460

Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM. Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection , Int J Gynecol Cancer, 34: 2024,969-974